MEDVi Pricing Explained: First-Month Rate vs Semaglutide Refill Costs

Last reviewed: September 13, 2026 Last updated: September 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

MEDVi offers compounded semaglutide injection at a first-month introductory rate of $179, then $299 per month thereafter; tirzepatide starts at $279 introductory, then $399 ongoing (pricing captured September 4, 2026 from medvi.com checkout flow). Those ongoing refill prices produce a 12-month effective monthly average of $289 for semaglutide injection and $389 for tirzepatide—figures materially higher than the advertised first-month rate. PlexusDx publishes flat month-to-month pricing with no introductory step: $189/month for semaglutide injection and $289/month for tirzepatide injection, every month. Over a full year on semaglutide injection, the difference is $1,200 ($100 per month on average); on tirzepatide, also $1,200. Both programs bundle medication, clinician consult, shipping, and support with no separate membership fee on compounded plans, and both permit monthly cancellation. The decision hinges on whether MEDVi's care-coaching model and free dietitian visit outweigh the higher recurring cost, or whether a flat-rate structure with transparent upfront pricing better suits long-term treatment planning.

At-a-glance comparison

All pricing from provider checkout flows or published product pages. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

MEDVi's first-month vs refill pricing structure

MEDVi displays pricing after you complete a health questionnaire. For compounded semaglutide injection, the checkout flow shows a first-month introductory rate of $179, then $299 per month for every subsequent refill. Compounded tirzepatide is priced at $279 introductory, then $399 ongoing. Semaglutide oral tablets carry a $70 surcharge over injection, making the first month $249 and refills $369 (medvi.com checkout, captured September 4, 2026).

Dose increases do not raise the monthly price—whether you remain at a starting dose or titrate to the maximum, the refill cost stays $299 for semaglutide or $399 for tirzepatide. Every monthly charge includes medication compounding, clinician care, unlimited messaging support, and shipping; there is no separate membership fee on the compounded pathway. MEDVi bills monthly with no contract, and you may cancel at any time before the next refill (medvi.com, September 4, 2026).

MEDVi also offers 3-, 6-, and 12-month prepaid bundles with 0% financing through Klarna, spread over twelve months. The bundles are non-refundable for unused months, and MEDVi states it is "not a party" to the Klarna financing agreement. The specific per-month rate for these bundles is not published on the site; readers interested in a multi-month commitment should request bundle pricing during intake (medvi.com, July 20, 2026).

Calculating MEDVi's true 12-month cost

Because MEDVi's advertised rate applies only to the first shipment, a full-year cost projection requires summing the introductory month and eleven refills at the higher ongoing price. For semaglutide injection:

• Month 1: $179
• Months 2–12 (11 refills): 11 × $299 = $3,289
• 12-month total: $179 + $3,289 = $3,468
• Effective monthly average: $3,468 ÷ 12 = $289/month (our calculation)

For tirzepatide:

• Month 1: $279
• Months 2–12 (11 refills): 11 × $399 = $4,389
• 12-month total: $279 + $4,389 = $4,668
• Effective monthly average: $4,668 ÷ 12 = $389/month (our calculation)

For oral semaglutide tablets:

• Month 1: $249
• Months 2–12 (11 refills): 11 × $369 = $4,059
• 12-month total: $249 + $4,059 = $4,308
• Effective monthly average: $4,308 ÷ 12 = $359/month (our calculation)

The introductory discount represents a $120 reduction on semaglutide injection and tirzepatide in month one only. Spread across a year, that single discount lowers the average monthly cost by $10—from $299 to $289 for semaglutide, and from $399 to $389 for tirzepatide. Readers planning treatment longer than a few months should budget at the ongoing refill rate, not the first-month figure.

PlexusDx pricing: same rate every month

PlexusDx publishes every price tier on the product page before intake, with no introductory-then-refill step. Compounded semaglutide injection is $189 per month on a month-to-month plan, $169/month on a three-month commitment, and $149/month on a six-month commitment. Compounded tirzepatide injection is $289/month month-to-month, $269/month for three months, and $249/month for six months (plexusdx.com, July 20, 2026; confirmed September 13, 2026). The same price applies at every dose level, from initial titration through maintenance.

Every charge includes the compounded medication, licensed-provider consultation, prescription, and shipping. There is no membership fee. A free check-in with a Doctor of Pharmacy is available to all active patients. An optional test is offered at $298 (or $99 for program members), but the test does not select or predict which medication a provider will prescribe—prescribing decisions rest with the licensed clinician (plexusdx.com, July 20, 2026).

Billing is monthly, and you may cancel at any time. Multi-month commitments are billed upfront and are non-refundable, but the per-month rate is lower. Over twelve months on the month-to-month semaglutide plan, total cost is 12 × $189 = $2,268; on tirzepatide, 12 × $289 = $3,468.

Side-by-side 12-month cost comparison

MEDVi totals include the first-month introductory rate plus eleven refills at the ongoing price. All figures our calculation from published monthly rates.

On both semaglutide and tirzepatide, PlexusDx's flat month-to-month rate produces a $1,200 lower twelve-month cost than MEDVi's intro-then-refill structure—an average of $100 per month. Readers on tighter budgets or planning treatment lasting several months may find that gap material. Those who value MEDVi's free care coaching and dietitian visit should weigh those services against the cost difference and confirm at intake whether coaching remains included at the ongoing rate.

What the programs include

MEDVi inclusions

MEDVi bundles compounded medication, a clinician consultation, unlimited messaging support, and shipping into the monthly charge. Additional support includes free care coaching and a free dietitian visit (medvi.com, July 20, 2026). Unlimited doctor calls are advertised, though whether "unlimited" means on-demand synchronous calls or asynchronous message-based consults should be confirmed during intake. Dose adjustments do not trigger price increases. The program requires a monthly refill form, and billing occurs each month with no long-term contract on the month-to-month pathway (medvi.com, September 4, 2026).

MEDVi also operates a branded-medication pathway (Wegovy, Zepbound) that carries a separate $99/month membership fee plus medication cost; final all-in pricing for the branded route was not visible at checkout in our September 4, 2026 capture.

PlexusDx inclusions

PlexusDx includes compounded medication, a licensed-provider consultation, prescription management, and shipping in every monthly charge. A free check-in with a Doctor of Pharmacy is available to discuss dosing, side effects, or titration questions. An optional test ($298, or $99 for active members) analyzes genetic variants that may influence GLP-1 metabolism, but the test does not determine medication selection—prescribing authority remains with the licensed provider (plexusdx.com, July 20, 2026). There is no membership fee. Billing is monthly, and cancellation is permitted at any time before the next cycle.

Decision factors

Pricing transparency and budgeting certainty

PlexusDx publishes every tier—month-to-month and multi-month commitments—on the product page before you begin intake, so you know the full recurring cost upfront. MEDVi displays pricing after the health questionnaire, and the first-month rate ($179 semaglutide, $279 tirzepatide) rises to the ongoing refill price ($299, $399) starting in month two. For readers building a treatment budget or comparing multiple providers, a published flat rate eliminates the need to calculate intro-vs-refill arithmetic.

Care-team configuration

MEDVi offers free care coaching and a free dietitian visit, services that may add value for readers new to GLP-1 therapy or seeking structured nutrition guidance alongside medication. PlexusDx provides a free check-in with a Doctor of Pharmacy—a pharmacotherapy specialist trained in medication management—but does not currently include a dedicated dietitian or health coach in the base package. Readers should assess whether their primary need is medication access and dosing support (where both programs deliver) or broader lifestyle coaching (where MEDVi's model may better fit).

Multi-month commitment options

MEDVi advertises 3-, 6-, and 12-month bundles with 0% financing through Klarna, but specific per-month bundle rates are not published. Bundles are non-refundable for unused months, and MEDVi states it is not a party to the Klarna agreement—readers should review Klarna's terms separately. PlexusDx publishes commitment discounts: three-month plans drop semaglutide to $169/month and tirzepatide to $269/month; six-month plans drop further to $149/month and $249/month. These commitments are billed upfront and are non-refundable, but the per-month savings are explicit before intake.

Dose-adjustment pricing

Both programs hold the monthly price constant across all dose levels. MEDVi states that dose increases do not raise cost; PlexusDx likewise charges the same rate whether you are at 0.25 mg or 2.4 mg semaglutide, or 2.5 mg vs 15 mg tirzepatide. This removes a common friction point seen in some competitor programs where higher doses trigger price tiers.

Review record and service reliability

MEDVi holds a 4.3-star rating on Trustpilot with approximately 15,000 reviews (Trustpilot suggested-company snapshot, captured September 4, 2026). PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). Both programs show broadly favorable review profiles; readers seeking detail on shipping speed, clinician responsiveness, or side-effect support should read recent reviews on both Trustpilot pages before deciding.

Choose MEDVi if…

• You value structured care coaching and want a free dietitian visit included in the base program.
• You prefer to complete a health questionnaire before seeing final pricing, and you are comfortable with a first-month discount that shifts to a higher ongoing rate.
• The $299/month semaglutide or $399/month tirzepatide refill price fits your long-term budget, and the $100–$110/month difference vs PlexusDx is outweighed by MEDVi's care-team model.
• You are considering a multi-month prepaid bundle with 0% Klarna financing and will request specific bundle pricing during intake.

Choose PlexusDx if…

• You want every price tier published before you start intake, with no intro-then-refill step or post-questionnaire reveal.
• A flat $189/month semaglutide or $289/month tirzepatide rate—saving $1,200 over twelve months compared to MEDVi's intro-plus-refills structure—better aligns with your treatment budget.
• You value pharmacotherapy expertise and prefer a free Doctor of Pharmacy check-in over a health-coaching model.
• You want the option to add a genetic test ($99 for active members) to explore genetic factors that may inform dosing or side-effect risk, while understanding that the test does not dictate prescribing decisions.
• You prefer transparent, published multi-month discounts with clear per-month rates before committing.

Strengths and limitations

MEDVi strengths

• Free care coaching and free dietitian visit broaden support beyond medication alone.
• First-month introductory pricing ($179 semaglutide, $279 tirzepatide) lowers the barrier to starting treatment.
• Dose increases do not raise cost.
• Monthly billing with no contract; cancel anytime.
• Multi-month bundles with 0% Klarna financing available (specific rates not published).
• 4.3-star Trustpilot rating with ~15,000 reviews demonstrates scale and generally positive service experience.

MEDVi limitations

• Ongoing refill price ($299 semaglutide, $399 tirzepatide) is materially higher than the advertised first-month rate, producing a $289–$389 effective monthly average over twelve months.
• Pricing appears after health questionnaire, not before intake.
• Multi-month bundle per-month rates are not published; readers must request pricing during enrollment.
• Oral semaglutide carries a $70/month surcharge over injection, raising the refill rate to $369.
• Over one year on month-to-month billing, total cost is $1,200 higher than PlexusDx's flat-rate structure for the same medication.

PlexusDx strengths

• Flat month-to-month pricing with no introductory-then-refill jump: $189 semaglutide, $289 tirzepatide, every month.
• All price tiers published on the product page before intake.
• Multi-month commitment discounts explicit and transparent: $169/$149 semaglutide, $269/$249 tirzepatide for three-/six-month plans.
• Free Doctor of Pharmacy check-in for dosing and side-effect questions.
• Optional genetic testing at $99 for active members.
• No membership fee.
• 4.3-star Trustpilot rating with 79% five-star reviews and 83% four stars or higher.
• $1,200 lower total cost over twelve months on both semaglutide and tirzepatide vs MEDVi's month-to-month path.

PlexusDx limitations

• No dedicated health coach or dietitian visit included in the base package.
• Genetic testing is optional and adds cost ($99 for members, $298 otherwise); the test does not determine medication selection.
• Multi-month commitments are billed upfront and non-refundable.

Important prescribing and regulatory context

Both MEDVi and PlexusDx operate telehealth models in which a licensed clinician reviews your intake, health history, contraindications, and treatment goals before deciding whether to issue a prescription. Neither program guarantees eligibility, medication type, starting dose, or treatment outcomes. Compounded semaglutide and tirzepatide are not FDA-approved; FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Common GLP-1 side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort; serious risks include pancreatitis, gallbladder disease, kidney injury, and potential thyroid tumors (seen in rodent studies). Both programs provide clinical support to manage side effects and adjust dosing, but neither can eliminate risk. Readers with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use GLP-1 receptor agonists. Discuss your full medical history, current medications, and contraindications with the prescribing clinician before starting treatment.

Methodology and freshness

MEDVi pricing, inclusions, and terms were captured September 4, 2026 from the medvi.com checkout flow after completing a sample health questionnaire. Additional MEDVi details (bundles, care coaching, dietitian visit) were captured July 20, 2026 from the same checkout and product-information pages. PlexusDx pricing and inclusions were captured July 20, 2026 from published product pages at plexusdx.com and confirmed September 13, 2026. Review ratings for both programs were captured from Trustpilot between September 4 and September 9, 2026.

Twelve-month cost totals and effective monthly averages are our calculation, derived by summing MEDVi's first-month introductory rate and eleven refills at the ongoing price, then dividing by twelve. PlexusDx totals multiply the published flat monthly rate by twelve. We label every derived figure as "our calculation" and provide the underlying monthly rates so readers can verify the arithmetic. Where evidence conflicts or specific figures (such as MEDVi's bundle per-month rates) are not published, we state the gap plainly and advise confirming at checkout. Readers should verify all pricing, inclusions, and terms at the provider's website or during intake before committing.

Frequently Asked Questions

Does MEDVi's $179 semaglutide price apply every month?

No. The $179 figure is a first-month introductory rate. Starting in month two, MEDVi's semaglutide injection refill price is $299 per month. Over twelve months, the effective average is $289/month (our calculation: $179 + eleven refills at $299 = $3,468 total ÷ 12).

How much do I save with PlexusDx over a full year?

On semaglutide injection, PlexusDx's month-to-month plan ($189/month) totals $2,268 over twelve months, compared to MEDVi's $3,468—a difference of $1,200. On tirzepatide, PlexusDx totals $3,468 vs MEDVi's $4,668, also $1,200 lower. The gap is $100 per month on average.

Does MEDVi offer multi-month discounts?

MEDVi advertises 3-, 6-, and 12-month prepaid bundles with 0% Klarna financing, but the specific per-month rate for each bundle is not published on the website. Bundles are non-refundable for unused months. Request bundle pricing during intake if you are considering a longer commitment.

What support does each program include?

MEDVi includes medication, clinician consult, unlimited support messaging, shipping, free care coaching, and a free dietitian visit—all in the monthly charge, with no separate membership fee. PlexusDx includes medication, consult, shipping, and a free Doctor of Pharmacy check-in, also with no membership fee. Neither program charges extra when your dose increases.

Are compounded semaglutide and tirzepatide FDA-approved?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Both MEDVi and PlexusDx work with licensed compounding pharmacies to prepare individualized formulations.

Sources

• MEDVi checkout flow and product pages, medvi.com – accessed July 20, 2026 and September 4, 2026
• PlexusDx product pages, plexusdx.com/products/semaglutide-injection and plexusdx.com/products/tirzepatide-injection – accessed July 20, 2026; confirmed September 13, 2026
• Trustpilot review profile, MEDVi – accessed September 4, 2026
• Trustpilot review profile, PlexusDx (trustpilot.com/review/plexusdx.com) – accessed September 9, 2026
• FDA guidance on compounded drugs – fda.gov

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.